2018
DOI: 10.1089/jmf.2018.4180
|View full text |Cite
|
Sign up to set email alerts
|

Anti-Inflammatory Effect of Ginsenoside Rh2-Mix on Lipopolysaccharide-Stimulated RAW 264.7 Murine Macrophage Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
21
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 37 publications
(23 citation statements)
references
References 46 publications
0
21
0
Order By: Relevance
“…The overproduction of NO is positively linked with excess iNOS expression. Thus, the release of NO was reduced as iNOS expression was blocked [42]. Accordingly, selective inhibitors of iNOS in inflammatory macrophages are considered to be effective therapeutics for inflammatory diseases [43].…”
Section: Discussionmentioning
confidence: 99%
“…The overproduction of NO is positively linked with excess iNOS expression. Thus, the release of NO was reduced as iNOS expression was blocked [42]. Accordingly, selective inhibitors of iNOS in inflammatory macrophages are considered to be effective therapeutics for inflammatory diseases [43].…”
Section: Discussionmentioning
confidence: 99%
“…Natural products (especially secondary metabolites of herbal medicinal plants) play therapeutic roles in treating numerous human diseases. Among these natural products, the biologically active compounds of Panax ginseng are famous around the world because of their strong pharmacological effects against numerous human diseases [1][2][3][4][5][6]. Historically, to produce biologically active minor ginsenosides, the ginseng plant was treated with heat or steam and was commonly known as red or black ginseng.…”
Section: Introductionmentioning
confidence: 99%
“…More than 80% of ginseng extract is composed of the major ginsenosides Rb1, Rc Rd, Re, and Rg1, which are categorized as protopanaxadiol (PPD)-and protopanaxatriol (PPT)-type ginsenosides based on the structure of the aglycon [9,10]. However, these major ginsenosides can be transformed into pharmacologically active minor ginsenosides, such as Rg3(S), F2, C-K, CM-c1, and Rh2, by microorganisms or recombinant enzymes [4,[6][7][8]. Minor ginsenosides exhibit various antitumor, antistress, anti-inflammatory, anticancer, immunomodulatory, anti-atherosclerotic, anti-allergic, anti-osteoporosis, antiproliferation, antidiabetic, antigenotoxic, and antihypertensive properties [1][2][3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%
“…Ginsenosides, the main active components of Panax ginseng Mayer ( P. ginseng ), are mainly classified into protopanaxadiol (PPD; Rb1, Rb2, Rb3, Rc, Rd, Rg3, and Rh2)- and protopanaxatriol (PPT; Re, Rg1, Rg2, and Rh1)-type saponins [ 12 ]. They have been shown to have various pharmacological effects, including anticancer and anti-inflammatory effects, and beneficial effects against cardiovascular diseases and immunodeficiency [ 13 , 14 , 15 , 16 ]. Among them, Rg1 attenuates hepatocellular apoptosis and inflammatory response in ischemia–reperfusion injury mouse models [ 17 ].…”
Section: Introductionmentioning
confidence: 99%